A Trump-Touted Covid Therapy Awaits Proof to Back Up His Boasts

Dec. 30, 2020, 12:00 PM

One day before the Republican National Convention kicked off, President Donald Trump and top drug regulator Stephen Hahn held a White House press conference to tout emergency authorization of a promising Covid-19 treatment.

Convalescent plasma, a soup of immune factors derived from the blood of recovered Covid-19 patients, had shown “an incredible rate of success” and would “save countless lives,” Trump said Aug 23. Yet more than four months later and with more than 330,000 U.S. coronavirus deaths reported since the pandemic began, the jury is still out how much the treatment benefits patients, if at all.

Stephen Hahn and Donald Trump during a news conference on Aug. 23.
Photographer: Stefani Reynolds/Bloomberg

It ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.